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Abstract
Japanese encephalitis virus(JEV), tick-borne encephalitis virus(TBEV), and eastern equine encephalitis virus (EEEV) can
cause symptoms of encephalitis. Establishment of accurate and easy methods by which to detect these viruses is
essential for the prevention and treatment of associated infectious diseases. Currently, there are still no multiple
antigen detection methods available clinically. An ELISA-array, which detects multiple antigens, is easy to handle,
and inexpensive, has enormous potential in pathogen detection. An ELISA-array method for the simultaneous
detection of five encephalitis viruses was developed in this study. Seven monoclonal antibodies against five
encephalitis-associated viruses were prepared and used for development of the ELISA-array. The ELISA-array assay is
based on a “sandwich” ELISA format and consists of viral antibodies printed directly on 96-well microtiter plates,
allowing for direct detection of 5 viruses. The developed ELISA-array proved to have similar specificity and higher
sensitivity compared with the conventional ELISAs. This method was validated by different viral cultures and three
chicken eggs inoculated with infected patient serum. The results demonstrated that the developed ELISA-array is
sensitive and easy to use, which would have potential for clinical use.
Background
Japanese encephalitis virus(JEV), tick-borne encephalitis
virus(TBEV), eastern equine encephalitis virus (EEEV),
sindbis virus(SV), and dengue virus(DV) are arboviruses
and cause symptoms of encephalitis, with a wide range
of severity and fatality rates [1]. Establishment of an
accurate and easy method for detection of these viruses
is essential for the prevention and treatment of asso-
ciated infectious diseases. Currently, ELISA and IFA are
the methods which are clinically-available for the detec-
tion of encephalitis viral antigens, but they could only
detect one pathogen in one assay [2,3].
There are a variety of different methods available for
identifying multiple antigens in one sample simulta-
neously, such as two-dimensional gel electrophoresis (2-
DE), protein chip, mass spectrometry, and suspension
array technology [4-6]. However, the application of
these techniques on pathogen detection is still in an
early phase, perhaps due to the complicated use and
high cost.
Antibody arrays for simultaneous multiple antigen
quantification are considered the most accurate methods
[7-10]. Liew [11] validated one multiplex ELISA for the
detection of 9 antigens; Anderson [12] used microarray
ELISA for multiplex detection of antibodies to tumor
antigens in breast cancer, and demonstrated that
ELISA-based array assays had the broadest dynamic
range and lowest sample volume requirements com-
pared with the other assays.
However, the application of ELISA-based arrays is cur-
rently limited to detection of cancer markers or inter-
leukins; no detection of pathogens has been reported. In
this study, we developed an ELISA-based array for the
simultaneous detection of five encephalitis viruses.
Seven specific monoclonal antibodies were prepared
against five encephalitis viruses and used to establish an
ELISA-array assay. The assay was validated using cul-
tured viruses and inoculated chicken eggs with patient
sera. The results demonstrated that this method com-
bined the advantage of ELISA and protein array (multi-
plex and ease of use) and has potential for the
identification of clinical encephalitis virus.
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Monoclonal antibody preparation
Monoclonal antibodies were prepared from hybridoma
cell lines constructed by Prof. Zhu et al. Purification was
conducted by immunoaffinity chromatography on pro-
tein G affinity sepharose [13]. Specific monoclonal anti-
bodies (4D5 against JEV, 2B5 against TBEV, 1F1 against
SV, 2B8 against serotype 2 DV, 4F9 against serotype 4
DV, 4E11 against EEEV, and 2A10 against Flavivirus)
were selected for this study. All of the antibodies were
raised according to standard procedures.
U s i n g4 D 5 ,2 B 5 ,1 F 1 ,2 B 8 ,4 F 9 ,a n d4 E 1 1a sc a p t u r e
antibodies, detection antibodies (2A10, 1 F1, and 4E11)
were coupled to biotin-NHS ester(Pierce, Germany) at
4°C for 3 h according to the manufacturer’s instructions.
Unincorporated biotin was removed by Desalt spin col-
umn (Pierce). Immunologic reactions were reported by
Streptavidin-HRP (CWBIO, Beijing, China) and Super
Signal ELISA Femto Maximum sensitive substrate. Puri-
fied goat-anti mouse antibody was used as a positive
control.
Virus culture
JEV and DV were cultured in C6/36 cells; SV, TBEV,
and EEEV were cultured in BHK-21 cells. The culture
of TBEV and EEEV was conducted in biosafety level 3
facility, however, JEV, DV and SV were conducted in
biosafety level 2 facility. Viral titers were determined by
the 50% tissue culture infectious dose (TCID50) method.
All the cultures were inactivated by 0.025% b-propiono-
lactone at 4°C overnight, then 37°C for 1 h to decom-
pose b-propionolactone.
Antibody spotting and optimization
Antibodies were spotted using a BIODOT machine
(BD6000;California, USA) on ELISA plates (30 nl/dot).
The plates were blocked with 3% BSA-PBS in 37°C for 1
h, followed by washing 3 times with PBS containing
0.1% Tween-20 for 2 min each. Then, the plates were
dried, sealed, and stored at 4°C before use [11].
When spotting, different spotting buffers and concen-
trations of capture monoclonal antibodies were evalu-
ated to optimize the ELISA-array assay. The
optimization was evaluated by dot morphology and sig-
nal intensity. The tested spotting buffers included 1 ×
phosphate buffer saline (PBS), PBS +20% glycerol, and 1
×P B S+2 0 %g l y c e r o l + 0 . 0 0 4 %T r i t o n - X 1 0 0 .Ar a n g eo f
monoclonal antibody concentrations (0.0125, 0.025,
0.05, 0.1, and 0.2 mg/ml) were compared.
Following a double antibody sandwich format, printed
plates were incubated sequentially with inactivated viral
cultures, biotin-labeled detecting antibody, HPR-labeled
avidin, and substrate, followed by signal evaluation.
ELISA-array analysis
Antigen binding was performed in PBS(containing 0.1%
T w e e n - 2 0a n d5 %F C S )a t3 7 ° Cf o r2h ,f o l l o w e db y
washing 3 times(1 × PBS containing 0.1% Tween-20).
Incubation of ELISA plates with biotinylated detecting
antibody cocktails was performed in PBS (containing
0.1% Tween-20 and 5% FCS) at 37°C for 2 h. After
washing, specific binding of the detecting antibodies was
reported by streptavidin-HRP and stained with Super
Signal ELISA Femto Maximum sensitive substrate
(Thermo scientific, Rockford, USA) [11,14,15]. Visualiza-
tion of the plate was performed in AE 1000 cool CCD
image analyzer(Beijing BGI GBI Biotech Company.,
LTD, China). The signal intensity and background of
each spot was read out and recorded with “Monster"-
software. The positive signals were defined as a signal
value > 400 and a signal value (sample)/signal value
(negative) > 2.
Conventional ELISA
The identical antibodies used in the ELISA-array format
were also tested in a conventional ELISA format to
determine the difference in sensitivity and specificity of
the two methods. The conventional ELISAs were per-
f o r m e da tt h es a m et i m ea st h eE L I S A - a r r a ya s s a y st o
ensure similar reaction conditions. The conventional
ELISAs were performed in an identical maner to the
ELISA-array, except that antibodies were coated at a
concentration of 2 μg/mL in PBS (pH 7.4), and substrate
TMB was used instead of Super Signal ELISA Femto
Maximum sensitive substrate [16,17].
Clinical sample treatment and chicken egg inoculation
Three serum samples were collected from patients with
nervous system symptoms and histories of tick bites.
The serum samples were treated with penicillin and
streptomycin, then inoculated into the allantoic cavities
of chicken eggs. 3 days later, the liquid was collected
and divided into two portions (one for inactivation and
one for RNA extraction). The RNA and inactivated sam-
ples were stored at -70°C before use.
Real-time RT-PCR assay
RNA was extracted from the inoculated chicken eggs
using a RNeasy mini kit (Qiagen Inc., Valencia, CA,
USA) according to the manufacturer’s instructions. All
RNA extraction procedures were conducted at BSL-3
facilities. The primers and probes were used as pre-
viously described [18]. The real-time RT-PCR was con-
ducted with a Quti-teck q-RT-PCR Kit (Qiagen Inc,).
The reaction consisted of 10 μL of 2 × reaction buffer
(0.2 μL reverse transcription enzyme, and 250 nmol/l
primers and probes). RNA and deionized water were
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with a LightCycler 2.0 (Roche, Switzerland) [19].
Results and discussion
Optimization of the ELISA-array assay
The spotted array layout is depicted in Figure 1 and the
efficacy of three different spotting buffers on the quality
of the printed ELISA-arrays were investigated by spot
morphology observation and signal intensity
comparison.
The spotting concentration of the capture antibodies
varied from 0.2 to 0.0125 mg/ml (each was serially
diluted 2-fold). The efficacy of the spotting concentra-
tion of the capture antibodies was evaluated by virus
culture detection, the proper spotting concentration was
determined by a combination of minimized cross reac-
tion and higher signal intensity. Figure 1 illustrates the
array layout and Figure 2 demonstrates the result of the
three spotting buffers and spot concentration of anti-
body 2B5 by TBE virus culture detection. Cross reaction
detection was also conducted by applying JEV, YF, and
DV cultures.
Spot morphology observation (Figures 2a, b, and 2c)
demonstrated that spotting buffer containing PBS with
20% glycerol produced tailed spot morphology; buffers
containing PBS alone and PBS with 20% glycerol
+0.004% Triton-X100 gave good spot morphology
(round and full). Buffers containing PBS with 20% gly-
cerol and PBS with 20% glycerol+0.004% Triton-X100
produced higher signal intensities than PBS alone. Thus,
PBS with 20% glycerol+0.004% Triton-X100 was
adopted as the optimized spotting buffer for subsequent
experiments. Simultaneously, the spot concentration
evaluation suggested that 0.05 mg/ml was optimal. At
this concentration, the signal intensity was higher and
the cross-reaction did not appear (Figure 2d). Conse-
quently, spotting concentration optimization of other
capture antibodies (4D5, 1F1, 4E11, and 2B8) demon-
strated that 0.05 mg/ml wasa l s os u i t a b l e ( d a t an o t
shown).
The optimized ELISA array layout is shown in Figure
3, which was applied in the following experiments.
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Figure 1 Print layout of antibodies spotted on ELISA plates,
spot volume = 30 nl.
   
 
 
Figure 2 Evaluation of different spotting buffers and antibody
concentrations in ELISA-array application. a spot morphology
visualization by using 20% glycerol-PBS buffer; b spot morphology
visualization by using PBS + 20% glycerol+0.004%Triton-X100 buffer;
c spot morphology visualization by using PBS buffer. d Signal
intensity comparisons of different solutions and spotting
concentration of 2B5.
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conventional ELISAs
Successful detection of viral pathogens requires a test
with high sensitivity and specificity. To evaluate the per-
formance of the designed antibody arrays, the specificity
and sensitivity of the individual analytes were examined.
By testing serially-diluted viral cultures, including DV-2,
DV-4, JEV, TBE, SV, and EEEV, the sensitivity of ELISA-
array and the identical conventional ELISA were com-
pared (Table 1). The detection limit of the two methods
was compared and demonstrated. The cross-reactivity
test was conducted using BHK-21 and vero cell lysate,
Yellow fever virus (YFV) cultures (5 × 10
5 TCID50/ml,
West Nile virus(WNV) cultures(2 × 10
6 TCID50/ml), and
Western equine encephalitis virus(1 × 10
7 TCID50/ml).
The results demonstrated that neither the ELISA-array
nor traditional ELISA displayed cross-reactivity.
Single and multiplex detection of TBEV, JEV, DV, SV, and
EEEV
Equal volumes of cultured TBEV, JEV, DV-2, DV-4, SV,
and EEEV were prepared for single sample detection;
two or three of the cultures were mixed for multiplex
detection. A cocktail of biotin conjugated antibody
(2A10, 4E11, and 1F1) was used in all tests. The results
demonstrated that for all virus combinations, each virus
was detected specifically, with no false-positive or-nega-
tive results (Figures 4 and 5).
Validation by mock clinical samples
Chicken eggs inoculated with infected human serum
were used for validation of the ELISA-array assay. All
samples showed high reaction signals with capture anti-
body 2B5, which was specific for TBEV (Figure 6b). The
ELISA-array assay suggested that the three patients were
all infected with TBEV.
To verify the results tested by ELISA-array, RNA
extracted from chicken eggs was applied to a real time-
RT-PCR assay using primers and probes targeting
TBEV. The results were also positive (Figure 6a). The
consensus detection results confirmed that the ELISA-
array assay was reliable.
Discussion
To be widely used in the clinical setting, the detection
system should be easy to use and can be performed by
untrained staff with little laboratory and experimental
experience. Moreover, when the volume of the clinical
samples is limited and an increasing number of patho-
gens per sample needs to be tested, the detecting system
should be high-throughput to allow detection of multi-
ple pathogens simultaneously [6,20,21]. Multiple detec-
tion, easy to use, and affordability are requirements for
detection methods in the clinical setting. Thus, an
ELISA-array, which combines the advantages of ELISA
and protein array, meets the above requirements.
It has been reported that an ELISA-array has been
used in the diagnosis of cancer and auto-allergic disease
[7,12]; however, No study has reported the detection of
viral pathogens. In this study, we developed a multiplex
ELISA-based method in a double-antibody sandwich
format for the simultaneous detection of five encephali-
tis-associated viral pathogens.
The production of a reliable antibody chip for identifi-
cation of microorganisms requires careful screening of
capture of antibodies [14]. Cross-reactivity must be
minimized and the affinity of the antibody is as impor-
tant as the specificity. First, we prepared and screened
23 monoclonal antibodies against eight viruses and veri-
fied the specificity and affinity to the target viruses by
an immunofluorescence assay. Then, the antibodies
were screened by an ELISA-array with a double-anti-
body sandwich ELISA format. The antibodies which
produced cross-reactivity and low-positive signals were
excluded. Finally, six antibodies were selected as capture
antibodies. Another monoclonal antibody, 2A10, which
could specifically react with all viruses in the genus Fla-
vivirus was used for detecting antibody against DV, JEV,
and TBEV. For the detection of EEEV and SV, although
the detecting and trapping antibodies were the same
(1F1 and 4E11, respectively), the antibodies produced
excellent positive signals. The epitope was not defined;
however, we suspect that the antibodies both target the
surface of the virions. As one virion exits as, many with
the same epitope appear, thus no interference occurred
using the same antibody in the double-antibody sand-
wich format assay.
Currently, the availability of antibodies suitable for
an array format diagnostic assay is a major problem. In
the ELISA-array assay, this problem exists as well.
Because of the limitation of available antibodies, this
assay could only detect 5 pathogens. In the future,
with increasing numbers of suitable antibodies, espe-
cially specific antibodies against Flavivirus, this ELISA-
array might be able to test more pathogens and be of
greater potential use.
Table 1 Detection limit comparison between ELISA-array
and traditional ELISA
ELISA-array (TCID50/ml) Traditional ELISA(TCID50/ml)
JEV 1.5 × 10
4 6×1 0
4
TBEV 8 × 10
3 8×1 0
4
DV2 6.25 × 10
4 1.25 × 10
5
EEEV 8 × 10
4 1.6 × 10
5
DV4 6 × 10
4 6×1 0
5
SV 2.5 × 10
6 1.25 × 10
6
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detection, the assay protocol was optimized. In addition
to the dotting buffer, the capture antibody concentration
and the different virus inactivation methods (heating
and b-propiolactone) were also compared and evaluated.
Heat inactivation was performed by heating the viral
cultures at 56°C for 1 h, and b-propiolactone inactiva-
tion was performed by adding b-propiolactone into the
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Figure 4 The ELISA array detection results for single encephalitis virus. a:Japanese encephalitis virus(JEV); b:Tick born encephalitis virus
(TBEV); c:Sindbis virus(SV); d:Dengue-4 virus(DV-4);E:Dengue-2 virus(DV-2);F:Eastern equine encephalitis virus(EEEV).
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incubating at 4°C overnight, then decomposing b-pro-
piolactone at 37°C for 1 h. The performance was evalu-
ated based on the infectivity experiments and detecting
the limit of virus titers (data not shown). The infectivity
experiments demonstrated that both of the two methods
could totally inactive the viruses, but the sensitivity limit
assay suggested that virus treated by b-propiolactone
   
          A                                            B  
 
                C                                      D  
 
                 E  
Figure 5 The ELISA array detection results for multiplex encephalitis virus. a: DV-2 and EEEV; b: TBEV and DV2; c:TBEV and EEEV; d:J E V ,
TBEV and DV-4; e: DV-2, DV-4 and TBEV.
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method. Thus, b-propiolactone treatment was chosen as
the virus-inactivation method.
A conventional ELISA is a standard method in many
diagnostic laboratories. We compared the ELISA-array
with a conventional ELISA and confirmed that the
advantage of the ELISA-array was evident with com-
parable specificity and higher sensitivity than ELISA.
The time required for the ELISA-array is significantly
less than for conventional ELISA (4 h vs. a minimum
of 6 h, respectively). Furthermore, less IgG is required
for printing than for coating ELISA plates. Coating of
a single well in microtiter plate requires 100 μlo fa1
μg/ml antibody solution, which is equivalent to 100 ng
of IgG. For the ELISA-array, only 30 nl of a 50 μg/ml
antibody solution is required for each spot, which is
equivalent to 1.5 ng of IgG. With the characteristics of
ease of use, sensitivity, specificity, and accuracy, the
ELISA-array assay would be widely accepted for clini-
cal use.
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